Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3446 (116th)

National Commission on Scleroderma and Fibrotic Diseases Act of 2019

referredUnited States· United States Congress· EN

Introduced

24 June 2019

Last action

25 June 2019 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. King, Peter T. [R-NY-2], Rep. Engel, Eliot L. [D-NY-16], Rep. Thompson, Bennie G. [D-MS-2], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Jayapal, Pramila [D-WA-7], Rep. Rice, Kathleen M. [D-NY-4], Rep. Clay, Wm. Lacy [D-MO-1], Rep. Levin, Andy [D-MI-9], Rep. Beatty, Joyce [D-OH-3], Rep. Lowey, Nita M. [D-NY-17], Rep. McGovern, James P. [D-MA-2], Rep. Rose, Max [D-NY-11], Rep. Morelle, Joseph D. [D-NY-25], Rep. Davis, Rodney [R-IL-13], Sen. Welch, Peter [D-VT], Rep. Clarke, Yvette D. [D-NY-9], Rep. DelBene, Suzan K. [D-WA-1], Rep. Suozzi, Thomas R. [D-NY-3], Rep. Maloney, Carolyn B. [D-NY-12], Rep. Brindisi, Anthony [D-NY-22], Rep. Tipton, Scott R. [R-CO-3], Rep. Tonko, Paul [D-NY-20], Rep. Delgado, Antonio [D-NY-19], Rep. Espaillat, Adriano [D-NY-13], Rep. Perlmutter, Ed [D-CO-7], Rep. Higgins, Brian [D-NY-26], Rep. Rouda, Harley [D-CA-48], Rep. Jackson Lee, Sheila [D-TX-18], Rep. Neguse, Joe [D-CO-2], Rep. Raskin, Jamie [D-MD-8], Rep. Posey, Bill [R-FL-8], Rep. Lee, Susie [D-NV-3], Rep. Larsen, Rick [D-WA-2], Rep. Axne, Cynthia [D-IA-3], Rep. Levin, Mike [D-CA-49], Rep. Phillips, Dean [D-MN-3], Rep. Heck, Denny [D-WA-10], Rep. Smith, Adam [D-WA-9], Rep. Gottheimer, Josh [D-NJ-5], Rep. Spanberger, Abigail Davis [D-VA-7], Rep. Lofgren, Zoe [D-CA-18], Rescom. González-Colón, Jenniffer [R-PR-At Large], Rep. Pingree, Chellie [D-ME-1], Rep. Stevens, Haley M. [D-MI-11], Rep. McMorris Rodgers, Cathy [R-WA-5], Rep. Crow, Jason [D-CO-6], Rep. Pocan, Mark [D-WI-2]

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

National Commission on Scleroderma and Fibrotic Diseases Act of 2019 This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 24 June 2019

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 24 June 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 24 June 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 25 June 2019

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 24 June 2019

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 24 June 2019

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 24 June 2019

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.